We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+24.16%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$375B
AUM Growth
+$72.8B
Cap. Flow
+$9.25B
Cap. Flow %
2.47%
Top 10 Hldgs %
20.56%
Holding
4,266
New
170
Increased
1,923
Reduced
1,788
Closed
190

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$478M
2
RTN
Raytheon Company
RTN
+$318M
3
MRK icon
Merck
MRK
+$257M
4
JNJ icon
Johnson & Johnson
JNJ
+$251M
5
QCOM icon
Qualcomm
QCOM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 13.79%
3 Financials 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
3801
Lineage Cell Therapeutics
LCTX
$268M
$69K ﹤0.01%
78,885
-331,600
-81% -$292K
LONE
3802
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$68K ﹤0.01%
143,843
+50,131
+53% +$31.3K
CPIX icon
3803
Cumberland Pharmaceuticals
CPIX
$118M
$67K ﹤0.01%
20,214
RDI icon
3804
Reading International Class A
RDI
$33.2M
$67K ﹤0.01%
15,836
-51,559
-77% -$194K
TMDI
3805
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$67K ﹤0.01%
80,272
+31,252
+64% +$16K
INOD icon
3806
Innodata
INOD
$2.03B
$66K ﹤0.01%
48,963
OTLK icon
3807
Outlook Therapeutics
OTLK
$166M
$66K ﹤0.01%
2,543
CNSY
3808
Cerenome, Inc. Common Stock
CNSY
$25.5M
$66K ﹤0.01%
83
WTER
3809
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$66K ﹤0.01%
3,094
FSTX
3810
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$66K ﹤0.01%
11,285
DS
3811
DELISTED
Drive Shack Inc.
DS
$66K ﹤0.01%
35,788
-167,537
-82% -$275K
VEDL
3812
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$66K ﹤0.01%
11,791
-7,028
-37% -$33.2K
ALDX icon
3813
Aldeyra Therapeutics
ALDX
$86.9M
$65K ﹤0.01%
15,548
-51,246
-77% -$187K
AWRE icon
3814
Aware
AWRE
$26.4M
$64K ﹤0.01%
19,865
MITT
3815
TPG Mortgage Investment Trust
MITT
$214M
$64K ﹤0.01%
6,671
-38,852
-85% -$371K
PPIH
3816
Perma-Pipe International
PPIH
$216M
$64K ﹤0.01%
11,453
HYPD
3817
Hyperion DeFi Inc
HYPD
$42.9M
$63K ﹤0.01%
278
LIQT icon
3818
LiqTech
LIQT
$19.7M
$63K ﹤0.01%
1,448
INFI
3819
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$63K ﹤0.01%
69,505
NTWK icon
3820
NetSol Technologies
NTWK
$49.3M
$61K ﹤0.01%
22,656
VVR icon
3821
Invesco Senior Income Trust
VVR
$459M
$61K ﹤0.01%
17,515
+1,261
+8% +$4.28K
PMD
3822
DELISTED
Psychemedics Corporation
PMD
$61K ﹤0.01%
11,074
VET icon
3823
Vermilion Energy
VET
$1.72B
$60K ﹤0.01%
13,441
-18,471
-58% -$87K
ACR
3824
ACRES Commercial Realty
ACR
$101M
$59K ﹤0.01%
7,330
-35,206
-83% -$268K
CHGA
3825
Change Agents Corporation Common Stock
CHGA
$2.94M
$59K ﹤0.01%
207
-4
-2% -$978

Similar funds

Bank of New York Mellon's Q2 2020 Portfolio in Review

As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
  • Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
  • Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
  • Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
  • Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
  • Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
  • Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.

Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.